ARG70635

Hantaan Virus Glycoprotein peptide

Hantaan Virus Glycoprotein peptide for Blocking

Overview

Product Description The peptide is used for blocking the activity of anti-Hantaan Virus Glycoprotein antibody ARG46771
Tested Application BL
Target Name Hantaan Virus Glycoprotein
A.A. Sequence 18 amino acids near the amino terminus of the Hantaan virus glycoprotein.

Application Instructions

Application Suggestion
Tested Application Dilution
BLAssay-dependent
Application Note This peptide usually blocks anti-Hantaan Virus Glycoprotein antibody ARG46771
activity completely by incubating the peptide with equal volume of antibody for 30 min at at 37°C.

Properties

Form Liquid
Buffer PBS (pH 7.2), 0.02% sodium azide and 0.1% BSA
Concentration 200 µg/ml
Storage Instruction Store peptide at -20°C, stable for one year. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Background Hantaan virus (HNTV) is the prototype virus of the genus hantavirus of the family Bunyaviridae, an enveloped, negative-sense RNA virus that is the eiological agent of Korean hemorrhagic fever (1). The two glycoproteins of HNTV, G1 and G2, are encoded as a continuous open reading frame to produce a polypetide precursor which is then processed to yield two glycoproteins (2). During infection both glycoproteins are found in the Golgi complex and co-expression is considered as a prerequisite for localization to the Golgi complex (2).